MedPath
FDA Approval

Griseofulvin

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
October 25, 2010
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Griseofulvin(125 mg in 5 mL)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Physicians Total Care, Inc.

Physicians Total Care, Inc.

194123980

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Griseofulvin

Product Details

NDC Product Code
54868-5234
Application Number
ANDA062483
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
October 25, 2010
ALCOHOLInactive
Code: 3K9958V90MClass: IACT
Code: 32HRV3E3D5Class: ACTIBQuantity: 125 mg in 5 mL
FD&C RED NO. 40Inactive
Code: WZB9127XOAClass: IACT
DOCUSATE SODIUMInactive
Code: F05Q2T2JA0Class: IACT
FD&C YELLOW NO. 6Inactive
Code: H77VEI93A8Class: IACT
MAGNESIUM ALUMINUM SILICATEInactive
Code: 6M3P64V0NCClass: IACT
MENTHOLInactive
Code: L7T10EIP3AClass: IACT
METHYLPARABENInactive
Code: A2I8C7HI9TClass: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3Class: IACT
PROPYLPARABENInactive
Code: Z8IX2SC1OHClass: IACT
SUCROSEInactive
Code: C151H8M554Class: IACT
WATERInactive
Code: 059QF0KO0RClass: IACT
SACCHARIN SODIUMInactive
Code: SB8ZUX40TYClass: IACT
SODIUM ALGINATEInactive
Code: C269C4G2ZQClass: IACT
© Copyright 2025. All Rights Reserved by MedPath